TABLE 4.
Study | Design | Sample size | Pre‐EECP | Post‐EECP | p‐value | Data collection time points |
---|---|---|---|---|---|---|
Subramanian et al, 2016 11 | Open‐label study | 72 | 121.10 ± 11.84 | 114.66 ± 13.63 | 0.001 | Before and after 36 sessions |
Briath et al, 2010 3 | Sham‐controlled randomized trial | 42 | 135 ± 20.5 | 127 ± 17.4 | 0.004 | Before and after 35 sessions |
Michaels et al, 2002 34 | Prospective, randomized, blinded study | 10 | 116 ± 20 | 99 ± 26 | 0.002 | At baseline and during EECP therapy |